Digital health program aims to ease menopause symptoms and cut heart risk in women with abdominal obesity

NCT ID NCT07713862

Not yet recruiting Disease control Sponsor: National University Health System, Singapore Source: ClinicalTrials.gov ↗

First seen Jul 20, 2026 · Last updated Jul 24, 2026 · Updated 3 times

Summary

This study tests whether a personalized digital health program — using a smartphone app, wearable devices, and lifestyle coaching — can help midlife women with abdominal obesity improve their diet, physical activity, sleep, and menopausal symptoms. Participants will wear a smartwatch, log food and symptoms in an app, and receive tailored recommendations. The goal is to see if this approach can reduce belly fat and improve heart health during the menopause transition.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: a personalized digital health program using a smartphone app, wearable devices, and lifestyle coaching
What this could lead to: If successful, this approach could offer a non-drug way to help midlife women manage menopausal symptoms and reduce heart disease risk.
What could go wrong: This is an early observational study without a control group, so it cannot prove cause and effect. Results may not apply to women not using smartphones or wearables.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MENOPAUSE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MENOPAUSE

More trials for these conditions

Other studies related to the condition(s) this trial covers.